As Senior Vice President & Chief Technology Officer, Said Saim, Ph.D., advances EyePoint Pharmaceuticals’ development and manufacturing activities through his strategic leadership, product development, and effective planning expertise, which spans more than 30 years. Prior to joining EyePoint in 2019, Dr. Saim served as Vice President, Pharmaceutical Development, at Collegium Pharmaceutical, where his responsibilities included managing formulation development, clinical trial manufacturing, and commercial manufacturing for controlled-release dosage forms. He also served as Senior Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc., where he led a team of engineers and scientists in charge of process development, scale up, and technology transfer of North American products. Dr. Saim began his career as an Assistant Research Professor at the Higuchi BioSciences Center for Drug Delivery Research. He holds a Ph.D. in Chemical Engineering from the University of Kansas, has published 22 papers in engineering and science journals, and holds 18 patents.